NCT04915495View on ClinicalTrials.gov

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

NAEnrolling by invitationINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Cervical Dysplasia
Interventions
DIAGNOSTIC_TEST

LuViva Advanced Cervical Scan

Multimodal hyperspectral device

Trial Locations (4)

23502

Tidewater Clinical Research, Norfolk

30322

Emory University- Winship Cancer Institute, Atlanta

35233

University of Alabama Birmingham- Heersink School of Medicine, Birmingham

48706

Great Lakes Bay Health Centers, Bay City

Sponsors
All Listed Sponsors
lead

Guided Therapeutics

INDUSTRY